ClinicalTrials.gg
Not yet recruitingNCT07756164Updated Aug 10, 2026

The Effects of a Multicomponent Sleep & Recovery Supplement on Muscle Fatigue and Sleep

An interventional study of magnesium-based sleep & recovery supplement and Placebo Supplementation in Athletes and Healthy, sponsored by University of Exeter. Not yet recruiting. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-10.

Sponsored by University of Exeter · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
25
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Study summary

The goal of this clinical trial (randomised crossover study) is to learn if a multi-component sleep and exercise recovery supplement can improve sleep quality and enhance recovery following exercise in healthy, recreationally active adults aged 18-40.

The main questions it aims to answer are:

  1. Does the supplement reduce delayed onset muscle soreness (DOMS) following an intense exercise protocol?
  2. Does the supplement improve sleep quality?

Researchers will compare the supplement to a placebo (a look-alike tablet with no active ingredients) to see if the supplement improves exercise recovery and sleep quality. In this crossover design, all participants will receive both the supplement and the placebo in separate 2-week periods, with a 2-week washout period in between.

Participants will:

  • Take the supplement during one 2-week period and the placebo during another (order randomised), 30 minutes before bed each day
  • Complete an exercise protocol involving repeated leg extensions designed to induce muscle fatigue
  • Attend six laboratory visits, including baseline testing and follow-up assessments at 24 and 48 hours post-exercise
  • Complete daily sleep questionnaires during each supplementation period
  • Record food intake prior to exercise trials and replicate it for consistency
  • Perform muscle soreness assessments and single-leg jump tests before and after exercise, and during recovery
02

Conditions studied

  • Athletes
  • Healthy

Keywords

  • Muscle Damage
  • Sleep
  • Supplementation
  • Recovery
03

In context

Lead sponsor

University of Exeter is the lead sponsor of 140 studies on the registry; 25 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged between 18-40, healthy and non smokers
  • Recreationally active, exercise at least 2 times a week

Exclusion criteria

Exclusion Criteria:

    • Not have any injuries that would affect performance

      • Not taking any medications that could affect drowsiness or energy levels
      • Not taking any other dietary supplements high in magnesium
      • Not be pregnant
      • Not have any illness or medical condition that could make intense exercise unsafe
      • Not be participating in other studies that could interfere with the outcomes of this study
      • Not have any current sleep problems e.g. Insomnia
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Investigator)
Enrollment
25 participants (estimated)

Study arms

  • Experimental
    Magnesium-based sleep & recovery supplementation

    Supplementation of a magnesium-based sleep \& recovery supplement (2g/day for 2-weeks)

    Dietary Supplement: magnesium-based sleep & recovery supplement

  • Placebo comparator
    Placebo Supplementation

    Supplementation of placebo (2g/day for 2-weeks)

    Dietary Supplement: Placebo Supplementation

Interventions

  • Dietary supplementmagnesium-based sleep & recovery supplement

    magnesium-based sleep \& recovery supplement (2g/day for 2-weeks)

  • Dietary supplementPlacebo Supplementation

    Placebo Supplementation (2g/day for 2-weeks)

06

What researchers measure

Primary outcomes

  1. Changes in total work done

    Changes in total work done as measured by the Biodex

    Time frame: Following each 2-week supplementation period of either supplement

  2. Changes in work done (Flexion)

    Changes in work done (Flexion) as measured by the Biodex

    Time frame: Following each 2-week supplementation period of either supplement

  3. Changes in work done (Extension)

    Changes in work done (Extension) as measured by the Biodex

    Time frame: Following each 2-week supplementation period of either supplement

  4. Changes in Single Leg jump height

    Changes in Single Leg jump height (m)

    Time frame: Before and Immediately After Muscle Damaging Protocol at the End of Each 2-Week Supplementation Period

  5. Changes in Single Leg Jump hang time

    Changes in Single Leg Jump hang time (s)

    Time frame: Before and Immediately After Muscle Damaging Protocol at the End of Each 2-Week Supplementation Period

Secondary outcomes

  1. Changes in sleep quality

    Changes in sleep quality as measured by the Groningen Sleep Quality questionnaire where a lower score indicates better sleep quality.

    Time frame: Following each 2-week supplementation period of either supplement.

  2. Changes in perceived muscle soreness (Pain pressure threshold)

    Changes in perceived muscle soreness (Pain pressure threshold in Newtons) as measured by the muscle algometer where a higher score means a better outcome

    Time frame: Following each 2-week supplementation period of either supplement and 24hr and 48hr following the muscle damaging protocol.

  3. Change in Self-Reported Readiness to Train Score (5-Point Likert Scale)

    Change in perceived readiness to train or compete assessed using a self-reported 5-point Likert scale, where 1 = not at all ready (extremely fatigued/sore) and 5 = completely ready (fresh, no limitations)

    Time frame: Following each 2-week supplementation period of either supplement and 24hr and 48hr following the muscle damaging protocol

  4. Changes in Sleep Quality

    Changes in Sleep Quality as measured by the Consensus Sleep Diary.

    Time frame: Following each 2-week supplementation period of either supplement.

  5. Change in perceived recovery status (10-Point Likert Scale)

    Change in perceived readiness to train or compete assessed using a self-reported 10-point Likert scale, where 0 = very poorly recovered and 10 = fully recovered

    Time frame: Following each 2-week supplementation period of either supplement and 24hr and 48hr following the muscle damaging protocol

  6. Change in perceived overall muscle soreness (10-Point Likert Scale)

    Change in perceived readiness to train or compete assessed using a self-reported 10-point Likert scale, where 0 = no soreness and 10 = worse soreness imaginable

    Time frame: Following each 2-week supplementation period of either supplement and 24hr and 48hr following the muscle damaging protocol

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Yes

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Aug 2026; primary completion for Oct 2026, 2 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 16, 2026
First posted
Aug 10, 2026
StartEst.
Aug 2026
Primary completionEst.
Oct 2026
CompletionEst.
Dec 2026
Last update
Aug 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07756164
Responsible party
Sponsor
First posted
Aug 10, 2026
Start date
Aug 2026 (estimated)
Primary completion
Oct 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Aug 10, 2026

Study contacts

Tom G Gurney, PhD
Contact
t.g.gurney@exeter.ac.uk
+44 (0) 1326 370400

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion